Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Life Time Group Holdings Inc. Common Stock (LTH) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance

Life Time Group Holdings Inc. Common StockTrade
NeoGenomics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Life Time Group Holdings Inc. Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Life Time Group Holdings Inc. Common Stock trades at $40.07 (market cap $8.86B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: Life Time Group Holdings Inc. Common Stock is far larger — about 4.1× NeoGenomics Inc. Common Stock's market cap, and Life Time Group Holdings Inc. Common Stock is more actively traded (3,372,885 versus 2,228,400). Which is the better fit depends on your goals — on Pluang, investors hold Life Time Group Holdings Inc. Common Stock for 6 Days and NeoGenomics Inc. Common Stock for 0 Days on average.

LTHNEO
Market Cap
$8.86B$2.14B
Volume
3,372,8852,228,400
Sector
Consumer CyclicalHealth
52-Week High
$45.73$19.91
52-Week Low
$24.59$7.19
Typical Hold Time
6 Days0 Days
Enterprise Value
$12.91B$2.44B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Life Time Group Holdings Inc. Common Stock

Life Time Group Holdings (LTH) trades at $39.66, down 1.76% today, amid bullish technical signals and strong fundamental performance. The stock shows consistent earnings beats, with Q2 2026 EPS of $0.48 exceeding expectations by 28%. Recent expansion news includes new athletic clubs in Florida and Boston, highlighting growth initiatives. Analyst consensus remains strongly bullish with an 86.7% buy rating and $55.17 price target, implying 39% upside.

LTH presents a compelling growth story with expanding facilities and robust profitability margins. Key risks include execution of expansion plans and consumer discretionary spending sensitivity. The valuation at 21.7x P/E appears reasonable given 13% net margins and double-digit ROE. Near-term catalyst is Q3 2026 earnings on October 29, 2026, which could validate the bullish analyst outlook.

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LTH

No sentiment data available yet.

NEO
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Life Time Group Holdings Inc. Common Stock

Life Time operates fitness and lifestyle centers that offer gyms, classes, sports facilities, and wellness services.

Read more on LTH →

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →